×
Contact Us

Investor News Details

Investor News Details

Univar Solutions Pharmaceutical Ingredients Is Organized for Success in Europe, Middle East and Africa

< Back to Investor News
02/18/2020

DOWNERS GROVE, Ill., Feb. 18, 2020 /PRNewswire/ -- Univar Solutions Inc. (NYSE: UNVR) ("Univar Solutions" or "The Company"), a global chemical and ingredient distributor and provider of value-added services, today announced the extension of its Pharmaceutical Ingredients as a Dedicated Industry Vertical into Europe, Middle East and Africa.  This new group enables the company to globally serve the pharmaceutical ingredients market with expertise located in all major regions backed by a worldwide network of state-of-the-art Solutions Centers designed to meet growing customer demand.

Univar Solutions Pharmaceutical Ingredients Is Organized for Success in Europe, Middle East and Africa

Univar Solutions now has a truly globalized approach to the pharmaceutical ingredients market with the new industry vertical team combining with the already successful organizations operating in both North and Latin America.  Through this launch, Univar Solutions continues to invest in its dedicated Industry Vertical model, with Pharmaceutical Ingredients joining the already successful Beauty & Personal Care, Food Ingredients and Coatings, Adhesives, Sealants & Elastomers businesses in place across Europe, Middle East and Africa.

"Historically, there has been a greater emphasis on the regional market, however this organizational alignment will help improve performance and increase focus on the needs of pharmaceutical ingredient customers and suppliers, as well as reinforce our commitment to being a responsible solutions provider," said Matthew Ottaway, vice president of Focused Industries in Europe, Middle East and Africa for Univar Solutions.  "Of course our goal remains to safely and reliably deliver ingredients to our customers and recognizing that we can create greater value through specialization, we have launched this line of business with its own dedicated management, resources and approach to the market," added Ottaway. "This also includes a dedicated team of experienced pharmaceutical account managers, sales and technical personnel who have a Europe, Middle East and Africa focus with local insight."

Tobias Mesecke, director of Pharmaceutical Ingredients in Europe, Middle East and Africa for Univar Solutions said, "I believe the expertise that comes with a dedicated sales and technical team will enable Univar Solutions to build closer, more intimate relationships with customers and suppliers.  This change was made to adapt to the needs of our market and provide a greater depth of focus, ultimately bringing value to our customers and suppliers."

"In 2020, we look forward to creating value by delivering global technical expertise locally for customers and suppliers, serving the pharmaceuticals, nutraceuticals, animal health and medical devices markets," added Mesecke.  "Univar Solutions knows that partners in these markets view reliable and sustainable support, service and product offerings as core values. Our focus on Pharma gives customers and suppliers the assurance that Univar Solutions proactively manages short-term changes in regulations and thereby the effects on their business."

About Univar Solutions
Univar Solutions (NYSE: UNVR) is a leading global chemical and ingredient distributor and provider of value added services to customers across a wide range of industries. With the industry's largest private transportation fleet and North American sales force, a vast supplier network, deep market and regulatory knowledge, world-class formulation and recipe development, unparalleled logistics know-how, and industry-leading digital tools, Univar Solutions is a committed ally to customers and suppliers, helping them anticipate, navigate, and leverage meaningful growth opportunities. Learn more at www.univarsolutions.com

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. Potential factors that could affect such forward-looking statements include, among others: fluctuations in general economic conditions, particularly in industrial production and the demands of our customers; significant changes in the business strategies of producers or in the operations of our customers; increased competitive pressures, including as a result of competitor consolidation; significant changes in the pricing, demand and availability of chemicals; our indebtedness, the restrictions imposed by our debt instruments, and our ability to obtain additional financing; the broad spectrum of laws and regulations that we are subject to, including extensive environmental, health and safety laws and regulations; an inability to integrate the business and systems of companies we acquire or to realize the anticipated benefits of such acquisitions; potential business disruptions and security breaches, including cybersecurity incidents; an inability to generate sufficient working capital; increases in transportation and fuel costs and changes in our relationship with third party providers; accidents, safety failures, environmental damage, product quality and liability issues and recalls; major or systemic delivery failures involving our distribution network or the products we carry; ongoing litigation and other legal and regulatory risks; challenges associated with international operations; exposure to interest rate and currency fluctuations; negative developments affecting our pension plans and multi-employer pensions; labor disruptions associated with the unionized portion of our workforce; and the other factors disclosed in the section entitled "Risk Factors" in our most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission ("SEC"), as updated from time to time in our subsequent filings with the SEC. We caution you that the forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "comfortable with," "will," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and we do not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.

 

Univar Solutions - Innovate. Grow. Together. (PRNewsfoto/Nexeo Solutions, Inc.,Univar In)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/univar-solutions-pharmaceutical-ingredients-is-organized-for-success-in-europe-middle-east-and-africa-301007044.html

SOURCE Univar Solutions Inc.

Stock Quote: NYSE

NYSE: UNVR

Price 10.50

Change -1.08

% Change (-9.33%)

Volume 1,991,521

Intraday High $11.29

52 Week High $24.77

Intraday Low $10.46

52 Week Low $6.40

Today's Open $10.90

Previous Close $11.58

Mar 27, 2020 04:02 PM Pricing delayed 20 minutes

Contact Information

Heather Kos
Investor Relations
Univar Solutions
[email protected]
+1 844-632-1060

Owais Yusuf
Investor Relations
Univar Solutions
[email protected]
+1 844-632-1060

Liam McCarroll
Sustainability
Univar Solutions
[email protected]
+1 844-632-1060

Dwayne Roark
Media Relations
Univar Solutions
[email protected]
+1 331-777-6031


Email Alerts

Email Address: *
Mailing Lists *